在RA的新生物标志物:对诊断,预后和个性化治疗的影响
Marcelo Neto1, Beatriz Mendes1, Fernando Albuquerque1
1Rheumatology Department, Unidade Local de Saúde de Coimbra, Portugal.
Best practice & research. Clinical rheumatology
|November 16, 2024
概括
发现新的类风湿性关节炎 (RA) 生物标志物是改善早期诊断,监测疾病活动和个性化治疗策略以获得更好的患者结果的关键.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 对类风湿性关节炎 (RA) 病原体的理解有了显著的进步.
- 有针对性的疗法和新的策略改善了RA治疗.
- 在早期诊断,监测,预后和治疗优化方面仍然存在未满足的需求.
研究的目的:
- 审查近期关于类风湿性关节炎生物标志物的发展.
- 突出显示或有前途的临床相关性的生物标志物.
- 解决RA诊断,预后和治疗方面的差距.
主要方法:
- 对当前科学文献进行叙述性审查.
- 专注于生物标志物用于诊断精度,预后预测和治疗优化.
- 确定生物标志物的临床相关性的分析.
主要成果:
- 在识别潜在的RA生物标志物方面取得了重大进展.
- 几种生物标志物显示出增强诊断准确性的前景.
- 生物标志物正在出现,用于预测疾病预后和指导治疗选择.
- 新兴生物标志物有助于监测疾病活动和治疗反应.
结论:
- 生物标志物研究对于推进类风湿性关节炎治疗至关重要.
- 新的生物标志物有可能解决RA未满足的临床需求.
- 持续的研究将完善RA生物标志物的临床实用性.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
60
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
60
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5


